Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced September through October 2013.
As part of a continued effort to focus on its Diagnostics Information Services business, Quest Diagnostics Inc. has sold its colorectal cancer (CRC) screening test business Enterix Inc. to Australian oncology testing firm Clinical Genomics Technologies Pty. Ltd. (Sep.)
The history among the three firms goes back to 2003, when Quest got US rights to sell Enterix’s in-home fecal...